J Stroke.
2017 May;19(2):205-212. 10.5853/jos.2016.01655.
Nationwide “Hospital Emergent Capability Accreditation by Level-Stroke†Improves Stroke Treatment in Taiwan
- Affiliations
-
- 1Departments of Neurology and Occupational Medicine, Chi Mei Medical Center, Tainan, Taiwan, Republic of China.
- 2Department of Hospital and Health Care Administration, College of Recreation and Health Management, Chia Nan University of Pharmacy and Science, Tainan, Taiwan, Republic of China.
- 3Division of Neurology, Department of Internal Medicine, Taipei Veterans General Hospital, Hsinchu Branch, Hsinchu County, Taiwan, Republic of China.
- 4Department of Medical Affairs, Ministry of Health and Welfare, Executive Yuan, Republic of China, Taipei, Taiwan, Republic of China.
- 5Department of Neurology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Republic of China.
- 6Ministry of Health and Welfare, Executive Yuan, Republic of China, Taipei, Taiwan, Republic of China. Joyce12wang@gmail.com
- KMID: 2389207
- DOI: http://doi.org/10.5853/jos.2016.01655
Abstract
- BACKGROUND AND PURPOSE
Recombinant tissue plasminogen activator (rtPA) is one of the proven therapies that improve the outcome of patients with acute ischemic stroke (AIS). In 2009, the Ministry of Health and Welfare, Executive Yuan, Republic of China, launched the project "Hospital Emergent Capability Accreditation by Level-Stroke (HECAL-Stroke)" to improve AIS treatment in Taiwan. The current study was performed to determine whether the project launched by the government was effective in promoting rtPA therapy among AIS patients.
METHODS
All participating hospitals were verified and designated as "heavy duty (HD),""moderate duty (MoD)," or "medium duty (MeD)" according to the stroke center criteria. Four annual indices (rates of treatment, protocol adherence, in-time treatment, and complications) were recorded from 2009 to 2014 as outcome measures. The data were analyzed using the χ² test for significance.
RESULTS
The number of certified hospitals progressively increased from 74 to 112 during the 6-year period and finally consisted of 33 HD, 9 MoD and 70 MeD hospitals in 2014. The annual intravenous rtPA treatment rate increased significantly from 3.0% in 2009 to 4.5% in 2014. The protocol adherence rates were 95.7% in the HD group, 92.4% in the MoD group and 72.8% in the MeD group. The annual in-time treatment rate significantly improved from 26.0% in 2009 to 60.1% in 2014. The overall symptomatic intracranial hemorrhagic rate after rtPA treatment was 8.6%.
CONCLUSIONS
Initiation of the HECAL-Stroke project by the government significantly improved rtPA treatment in Taiwan.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Experiences of Accreditation of Medical Education in Taiwan
- Simple but Organized Neurology Residency Training Improves the Quality of Acute Stroke Care: From the Outset to Long-Term Effect
- Stroke: Morbidity, Risk Factors, and Care in Taiwan
- Registry-based stroke research in Taiwan: past and future
- High Daily Diastolic Blood Pressure Predicts Incident Stroke, Lacune, and Cerebral Microbleeds in CADASIL
